Table 3 Primary outcomes reported in randomized controlled trials assessing stents
| Â | Primary Outcome N (%) N = 132 |
|---|---|
Angiographic evaluation (e.g., coronary restenosis) | 62 (47.0) |
Major cardiac events and repeat revascularization | 25 (18.9) |
Major cardiac events, repeat revascularization and angiographic evaluation | 8 (6.1) |
Repeat revascularization | 7 (5.3) |
Major cardiac events | 8 (6.1) |
Other | 22 (16.7) |